Celon Pharma S.A. (CLN)
GPW
Closed
Aug 24, 2026
Day's Range
22.2052 wk Range
18.50Profile - CLN - Celon Pharma S.A.
Profile
Mic Code
XWAR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
553
Celon Pharma S.A. is a research-oriented biopharmaceutical company based in Poland, known for its focus on developing innovative therapies to address unmet medical needs. The company's primary purpose is to discover and commercialize novel treatments across various therapeutic areas, including oncology, neurology, and inflammatory diseases. Celon Pharma stands out for its robust pipeline of proprietary drug candidates, ranging from early-stage discovery to advanced clinical trials. Celon is particularly notable for its investment in cutting-edge research and development, utilizing state-of-the-art technologies such as specialized laboratories and collaborative networks with academic and research institutions. The company plays a key role in the pharmaceutical industry, not only in Poland but also increasingly in the international market, contributing to healthcare advancements. As a part of the evolving biotech landscape, Celon Pharma S.A. exemplifies the integration of science and innovation to transform complex medical challenges into therapeutic solutions, aiming to enhance patient care outcomes effectively.
Profile Details
Type
Common Stock
Ceo
Dr. Maciej Wieczorek Ph.D.
Address
Ogrodowa 2A
City
Lomianki
Zip
05-092
Country
Poland
Phone
48 227 51 59 33
Key Executives - CLN - Celon Pharma S.A.
Key executives
Cross Listings - CLN - Celon Pharma S.A.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
